Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jan 13;20(2):157–175. doi: 10.1007/s13770-022-00503-y

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Korean Tissue Engineering and Regenerative Medicine Society 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

PMC Copyright notice

Fig. 8 — Ang-1 Gel-modified ISL1-MSCs-Exo ameliorate cardiac fibrosis after myocardial infarction. A Schematic illustration showing the preparation of Ang-1 Gel and ISL1-MSCs-Exo. B Ang-1 gel increased the retention rate of ISL1-MSCs-Exo in the border area of myocardial infarction. C Angiogenesis in the border zone of ischemic myocardium at day 28 after myocardial infarction was detected by CD31 immunofluorescence staining. D Masson’s trichrome staining showing the degree of cardiac fibrosis in different treatment groups at day 28 after myocardial infarction operation. E, F Fibrosis areas and infarct wall thickness analysis.

(Adapted from Hu et al. ACS Appl Mater Interfaces. 2022;14:36,289–303, with permission from American Chemical Society [142])